Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07686328 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multicenter Feasibility Study With the VERAFEYE Imaging and Guidance System as Anatomical Navigation System

Study acronym: PRISM
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Feb 1, 2027 → Jul 1, 2027
See other at-risk trials from LUMA Vision Ltd.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Aug 1, 2026 to Nov 1, 2026 Show 4 more changesShow less
    • Primary and study completion pushed from Feb 1, 2027 to Jul 1, 2027
    • Eligibility criteria expanded, about 36 words
    • Secondary endpoints: details revised at 1 of 3 entries
    • Study description expanded, about 61 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
PRISM: A Multicenter Feasibility Study with the VERAFEYE Imaging and Guidance System as Anatomical Navigation System
Trial Details
NCT Number NCT07686328
Lead Sponsor LUMA Vision Ltd.
Conditions
(from sponsor)		 Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
Related terms Atrial Fibrillation
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov